Skip to contentS
Surgery Partners, Inc.
S
SGRYSurgery Partners, Inc. Q2 2024 · 10-Q
Revenue$762.10M$762.10M+14.2% vs Q2 2023 Net Income-$15.50M-$15.50MN/M vs Q2 2023 EPS Diluted-$0.12-$0.12N/M vs Q2 2023 Operating Income$84,800,000−13.1% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Surgery Partners, Inc. · CIK 1638833 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$55,900,000+112.5% Margins · derivedOperating margin11.1%−3.5 pt vs Q2 2023
Net margin-2.0%−4.9 pt vs Q2 2023
ended Jun 30, 2024 · filed Aug 6, 2024 · 37 d after period end